Health
Newly approved drugs in Canada lack key pediatric drug information – News-Medical.Net
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
Reviewed by Emily Henderson, B.Sc.Sep 1 2020
Newly approved drugs in Canada lack important pediatric drug information in their product monograph, according to an analysis led by McMaster University and McMaster Children’s Hospital.
This absence of pediatric information perpetuates “off-label” drug use which could be dangerous for this vulnerable population, say the authors. They add that Canadian regulatory mechanisms are needed to ensure submission of pediatric data by manufacturers when use …
-
General15 hours agoAlleged Croydon Park gunman Artemios Mintzas charged with 25 offences
-
Noosa News22 hours agoPrime Minister Anthony Albanese calls for political temperature to be ‘turned down’ after alleged death threat
-
General20 hours agoTeam Australia wins back-to-back Motocross of Nations titles
-
Noosa News21 hours agoYork family honours late son with tractor museum to fund cancer research